PROFIL TERAPI DAN EFEKTIVITAS PENGGUNAAN NIKARDIPIN PADA PASIEN STROKE HEMORAGI DI RSUD DR. ISKAK TULUNGAGUNG

Dimas Setyadi Putra; Aghnia Fuadatul Inayah; Wella Kumalasari; Dimas Setyadi Putra

doi:10.61902/motorik.v20i1.758

Dimas Setyadi Putra Padjadjaran University https://orcid.org/0000-0001-8176-4667
Aghnia Fuadatul Inayah Muhammadiyah Malang University
Wella Kumalasari Muhammadiyah Malang University
Dimas Setyadi Putra

DOI: https://doi.org/10.61902/motorik.v20i1.758

Keywords: Antihipertensi, Hipertensi, Nikardipin, Penyekat Kanal Kalsium, Storke Hemoragik, Antihypertension, Hypertension, Nicardipine, CCB, Calcium Channel Blocker

Abstract

Hemorrhagic stroke is a condition when brain’s blood vessels rupture and causes brain’s bleeding. This occurrence generates less blood supply to the brain which would drive cell death. Nicardipine is a CCB (Calcium Channel Blocker) antihypertensive drug that is used as a first-line intravenous drug to control hypertension in acute stroke patients when oral antihypertensive drugs are ineffective. This study aims at determining the effectiveness of nicardipine to reduce blood pressure in hemorrhagic stroke patients at Dr. Iskak Tulungagung Hospital. The current research adopted quantitative study by using a pre experiment design one group pre test-post test. The data was analyzed by using the Paired-Sample T Test through SPSS version 25 to determine the differences in blood pressure reduction. The current research is a retrospective study because the researcher identified Health Medical Record (Rekam Medik Kesehatan, RMK) data of 68 hemorrhagic stroke patients at Dr. Iskak Tulungagung Hospital from January - December 2020 period. The majority of the 62 (91%) patients as given medical therapy with nicardipin (0.5mcg/kgBB/minute) iv drips. The result shows that 66 patients (97%) are in the good condition when they have been discharged from the hospital. The study revealed a decrease in systole and diastole blood pressure in hemorrhagic stroke patients. The patient who was given nicardipine therapy at 0.5 mcg/kg/minute obtained systole p=0.000 and diastole p=0.000. Moreover, the patient who was threatened with nicardipine 1 mcg/kg/minute gathered systole p=0.000 and diastole p=0.008 with p<a (0.05). The outcome indicated that nicardipine effectively reduces blood pressure in hemorrhagic stroke patients in Dr. Iskak Tulungagung Hospital.

References

Varelas PN, Abdelhak T, Wellwood J, Shah I, Hacein-Bey L, Schultz L, et al. Nicardipine Infusion for Blood Pressure Control in Patients with Subarachnoid Hemorrhage. Neurocrit Care [Internet]. 2010;13(2):190–8. Available from: https://doi.org/10.1007/s12028-010-9393-7

Woloszyn A V, McAllen KJ, Figueroa BE, DeShane RS, Barletta JF. Retrospective Evaluation of Nicardipine Versus Labetalol for Blood Pressure Control in Aneurysmal Subarachnoid Hemorrhage. Neurocrit Care [Internet]. 2012;16(3):376–80. Available from: https://doi.org/10.1007/s12028-012-9700-6

Annisa L. Tata Laksana Terapi Stroke Hemoragik Pada Pasien Dengan Hipertensi: Sebuah Laporan Kasus. J Kedokt. 2022;11(3):976–9.

DiPiro JT, Matzke GR, Talbert RL, Wells BG, Yee GC, Posey LM. Pharmacotherapy: A Pathophysiologic Approach, Tenth Edition. McGraw-Hill Education; 2017.

Indonesia Ministry of Health. Laporan Nasional RISKESDAS. Vol. 44, Badan Penelitian dan Pengembangan Kesehatan. 2018. 1–200 p.

AHA. Explaining Stroke. In National Stroke Association. Explain Stroke Natl Stroke Assoc. 2019;43.

Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke . Stroke. 2019;50(12):e344–418.

Kawada K, Ohta T, Tanaka K, Kadoguchi N, Yamamoto S, Morimoto M. Risk factors of nicardipine-related phlebitis in acute stroke patients. J Stroke Cerebrovasc Dis. 2016;25(10):2513–8.

Poyant JO, Kuper PJ, Mara KC, Dierkhising RA, Rabinstein AA, Wijdicks EFM, et al. Nicardipine reduces blood pressure variability after spontaneous intracerebral hemorrhage. Neurocrit Care. 2019;30(1):118–25.

PERDOSSI. Indonesia (PERDOSSI). Guidel stroke tahun. 2011;

Alchuriyah S, Wahjuni CU. Faktor risiko kejadian stroke usia muda pada pasien rumah sakit Brawijaya Surabaya. J Berk Epidemiol. 2016;4(1):62–73.

Darotin R, Nurdiana N, Nasution TH. Analysis of Predictive Factors of Mortality in Hemorrhagic Stroke Patients at Soebandi Hospital Jember. NurseLine J. 2017;2(2):134–45.

Tiara UI. Hubungan Obesitas Dengan Kejadian Hipertensi. J Heal Sci Physiother. 2020;2(2):167–71.

Alessandro B. Risk factors for hemorrhagic stroke. J Clin Epidemiol. 2018;

Udayani NNW, Riastini NW, Putra IMAS. Perbedaan Efektivitas Penggunaan Obat Amlodipin Tunggal Dengan Kombinasi Amlodipin Dan Lisinopril Pada Pasien Hipertensi Rawat Inap Di Rs ‘X’tabanan Tahun 2017. J Ilm Medicam. 2018;4(2).

Yonata A, Pratama ASP. Hipertensi sebagai faktor pencetus terjadinya stroke. J Major. 2016;5(3):17–21.

An SJ, Kim TJ, Yoon B-W. Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: an update. J stroke. 2017;19(1):3.